ics and homeostasis [3, 4] , and that nitric oxide pathways of l-Arg on functional and biochemical parameters of nitric are disturbed in ARF [5] . Thus, decreased nitric oxide oxide signaling during the course of ischemic ARF. activity may be causally linked to ARF.
Methods. Ischemic ARF was induced in rats by bilateral
Nitric oxide is generated from l-arginine (l-Arg) by clamping of renal arteries for 45 minutes. l-Arg was applied nitric oxide synthases (NOS) [6] . Three different NOS all been identified in the kidney [7] [8] [9] . The major nitric
Results. Clamping resulted in 70% to 90% reduction of GFR oxide receptor, soluble guanylate cyclase [10, 11] , conand RPF, with a gradual recovery by day 14. Using an in situ assay with the oxidative fluorescent dye hydroethidine, sists of two subunits ␣ and ␤ [12] . Nitric oxide alters its increased tubular generation of O Ϫ 2 was detected in the early heme moiety and causes activation of the enzyme [13] , course of ischemic ARF, indicating enhanced oxidative stress.
followed by a rise in cyclic guanosine monophosphate These findings were accompanied by up-regulation of the nitric (cGMP) levels [14] . cGMP further mediates the nitric oxide receptor, soluble guanylate cyclase, and by significant oxide effector cascade by stimulating or inhibiting cerregulatory changes of inducible nitric oxide synthase (iNOS) and endothelial NOS expression. l-Arg had a beneficial effect tain phosphodiesterases, modulating cation ion channels, on GFR and RPF, decreased O Ϫ 2 production, diminished upor activating cGMP-dependent protein kinases (cGK-I regulation of soluble guanylate cyclase, and prevented up-reguand cGK-II) [15] . lation of iNOS.
The K m value of l-Arg for saturation of eNOS is 3 to concentrations [17, 18] . However, clinical studies and l-Arg supplementation reduces O Ϫ 2 generation and signifianimal models provide evidence that supplementation of cantly improves the expression of nitric oxide signaling proteins l-Arg has beneficial effects in diseases such as pulmonary as well as the recovery phase of ischemic ARF.
hypertension [19] , heart failure [20] , and endothelial dysfunction [21] . Furthermore, in a recent publication from our group, we detected significantly reduced tissue l-Arg Acute renal failure (ARF) is a common clinical comlevels in an animal model of toxic ARF [22] . Although tissue l-Arg levels in this model of ARF were still above the K m value for saturation of NOS, supplementation
With regard to renal function, beneficial effects of l-Arg have been described for the acute phase of renal  2003 by the International Society of Nephrology failure [24] , but only limited information is available on prophylaxis of pain, tramadol (2.0 mg/kg body weight) prolonged effects of l-Arg on ischemic ARF and on was applied subcutaneously. the downstream cascade of nitric oxide. Therefore, we l-Arg group (bilateral clamping and supplementation analyzed the impact of l-Arg supplementation on kidney with l-Arg). Identical procedure was performed as defunction during the recovery phase of ischemic ARF scribed for clamping group, except interperitoneal supover 14 days. For this purpose, we induced renal ischemia plementation of l-Arg (500 mg/kg body weight) in 0.5 in a rat model by bilateral clamping of renal arteries, mL 0.9% NaCl after 15 minutes of arterial clamping. followed by reperfusion. Supplementation of l-Arg was During the follow-up period, l-Arg was added to tap started within the phase of ischemia and was continued water (1%) [25] . throughout the follow-up period of 14 days. Kidney funcTo control for effects resulting from protein suppletion was monitored by measuring glomerular filtration mentation, the stereoisomeric d-Arg l-aspartate (d-Arg) rate (GFR) and renal plasma flow (RPF). The renal was used in the same manner as l-Arg. In order to apply expression of NOS, nitric oxide receptor soluble guanylyl comparable concentrations of d-Arg, preliminary dose cyclase, cGMP-dependent protein kinase (cGK-I), and finding experiments analyzing the pharmacokinetics of O Ϫ 2 generation visualized with hydroethidine fluoresoral and intraperitoneal supplementation of l-Arg and cence using confocal laser scan microscopy were deterd-Arg were performed as described below. mined.
Sham group (sham-operation and supplementation with saline). Identical procedure was performed as described METHODS for clamping group, except that in these animals no clamping of renal arteries was performed. A dose of Drugs 0.9% NaCl (0.5 mL) were applied intraperitoneally after
15 minutes of arterial clamping. Values of mean arterial pressure (MAP) and weight) were obtained from Charles River (Kissleg, Gerheart rate were recorded continuously for 6 hours to many). After a period of at least 24 hours in cages within exclude hemodynamic effects of the l-Arg application a temperature-controlled room with 12-12-hour lighton MAP or heart rate. Blood samples were taken as dark cycle, standard food with free access to drinking control prior to application of any substance, and at 6 water, anesthesia was performed by intraperitoneal aptime points thereafter. Enteral application of l-Arg and plication of xylacin hydrochloride (10 mg/kg body weight) d-Arg was performed via direct gastric infusion after and ketamine (100 mg/kg body weight). All operative laparatomy. Fluid loss was prevented by immediate cloprocedures were performed on thermoregulated heating sure of wounds. All blood samples were commercially boards to maintain body temperature at 37.5ЊC. Animals analyzed by Bioscientia (Ingelheim, Germany) with were divided into the following subgroups.
high-performance liquid chromatography (HPLC) analClamping group (bilateral clamping and supplementaysis for serum concentrations of l-Arg and d-Arg in tion with saline). Both kidneys were prepared carefully order to calculate pharmacokinetics. by a bilateral flank incision. Renal arteries were prepared and temporarily ligated on both sides in order to start Measurement of inulin and PAH clearance clamping with microclips simultaneously. Dispensable
For estimation of GFR and RPF, inulin and PAH fluid loss was prevented by closing wounds with sterile clearances were determined. The left femoral vein was strips during the clamping phase. Intraperitoneal applicannulated with a PE-10 (polyethylene) catheter. Inulin cation of 0.5 mL 0.9% NaCl was started 15 minutes after and PAH (1 mg of each substance solved in 0.25 mL clamping. Following the clamping period, both micro-0.9% NaCl) were applied as a bolus injection, followed clips were removed and sutures of muscular layers and skin were made to close the wound. For postoperative by constant infusion of both substances (inulin 5 mg/hour, PAH 5 mg/hour) using a Secura FT perfusor (B. Braun, luted 1:200), rabbit soluble guanylyl cyclase subunit ␣ (diluted 1:1000) and soluble guanylyl cyclase subunit ␤ Melsungen, Germany). After suprapubic incision, the (diluted 1:1000) polyclonal antibodies were a kind gift urine bladder was cannulated with a PE-50 (polyethylof Dr. Zabel [11] . Blots were subsequently incubated ene) catheter to measure urine flow and obtain urine with horseradish peroxidase-conjugated anti-rabbit IgG samples. When reaching a steady state after 30 minutes (1:2000, Dako, Hamburg, Germany) and were developed of infusion, urine was collected for 20 minutes and blood using a chemiluminescence kit (ECL Plus) following the samples were drawn subsequently. Samples were centrimanufacturer's instruction (Amersham Pharmacia Biofuged and stored at -20ЊC. Inulin concentrations in urine tech, Buckinghamshire, UK). Blots were analyzed densiand plasma were determined by fluorescence spectrometometrically using the Quantity One software (Bio-Rad try. PAH concentrations were measured by photospecLaboratories, Philadelphia, PA, USA). To describe varitrometry (Dynatech Lab, Guernsey, UK) using the anation of expressional changes in the different blots, valthrone method. Calculations of GFR and RPF were ues were expressed in percentages of the respective sham performed according to the equations: group as defined in the legend of each figure. GFR ϭ (I U * V U ) / (I P * t)
Oxidative fluorescent microscopy and
The oxidative fluorescent dye hydroethidine was used to evaluate in vitro production of superoxide (O
Hydroethidine is oxidized to ethidiumbromide (EtBr) where I U is inulin concentration in urine; U PAH is PAH selectively by O Ϫ 2 and is freely permeable to cells where concentration in urine; I P is inulin concentration in it is trapped by intercalating with the DNA [28] . When plasma; P PAH is PAH concentration in plasma; V U is urine oxidized, EtBr is excited at 488 nm with an emission volume; and t is time of measurement. spectrum of 610 nm. Animals, anesthetized as described before, received Organ preparation and tissue harvesting 50 g/100 g body weight hydrothidine (diluted in 10% After drawing blood samples, both kidneys were perdimethylsulfoxide in PBS 500 L/100 g body weight) fused under pressure-controlled conditions (100 mm Hg) intravenously [injected into the cannulated femoral vein with either ice-cold 0.9% NaCl for 20 seconds for Westfor 30 minutes using a Secura FT perfusor (B. Braun)]. ern blot analysis, or paraformaldehyde 4% in phosphateAfter 30 minutes of equilibration, animals were sacrificed. Tissue was harvested and organs were fixed as buffered saline (PBS) for hydroethidine fluorescence described before, and shock-frozen in liquid nitrogen. confocal laser microscopy. Kidneys were removed, and
Cryoprotected frozen kidney sections (5 m) were prefor some experiments, dissected into cortex, medulla pared and immediately scanned using a MRC-1024 laser (outer and inner stripe of the outer medulla), and papilla scanning confocal microscope (Bio-Rad Laboratories) (inner medulla). Then, kidney zones and whole kidneys equipped with a krypton/argon laser and a Axiovert 135 were snap-frozen in liquid nitrogen and stored at -80ЊC.
TV microscope (Carl Zeiss, Inc., Oberkochen, GerProtein immunoblot many). Fluorescence was detected with a 585 nm longpass filter. Laser settings were identical for acquisition For Western blot analysis, frozen whole kidneys were of images from day 1, 3, 7, and 14 of l-Arg and clamping homogenized using a stainless steel mortar cooled by group as well as specimens of sham group. For semiquanliquid nitrogen, dissolved in lysis buffer containing 25 titative evaluation of superoxide formation, four to six mmol/L Tris-HCl, 7 mmol/L reduced glutathione, 0.5 images of each treatment group were analyzed densitommol/L ethylenediaminetetraacetic acid (EDTA), 0.2 metrically using the Quantity One software (Bio-Rad mol/L phenylmethylsulfonyl fluoride (PMSF), 1 mol/L Laboratories). To describe variation of fluorescence inleupeptin, 1 mol/L pepstatin, 1 mol/L trans-epoxysuctensity, values were expressed as the percentage of the cinyl-L-leucylamido butane, and 1 mg/mL trypsin inhibirespective sham group. tor, and further minced with an ultrasonic disperser UW 70 (Bandelin Electronic, Berlin, Germany). For Statistical analysis analysis of expression of cGMP-dependent protein kiData are expressed as mean Ϯ standard error of the nase, different kidney zones, dissected into cortex and mean (SEM). Statistical analysis between experimental medulla, were used. Total protein was measured in samgroups was performed by applying the t test for unpaired ples using the Bradford method [26] . Samples of protein groups. In Figures 1, 2B , 3, 4, 5, and 6, "sham" was set (5 to 40 g) were analyzed by Western blot with the to 100%, and data of the treatment groups "clamping" respective antibodies. Rabbit iNOS polyclonal antibody and "clamping ϩ l-Arg" are expressed as variation from (diluted 1:1000) and mouse eNOS monoclonal antibody "sham." The N value refers to the number of animals (diluted 1:250) were from Transduction Labaratories used in the experiments. A probability value P Ͻ 0.05 was considered statistically significant. (Lexington, KY, USA); cGK-I polyclonal antibody (di-rate was below 5% in all treatment groups (data not shown).
GFR and RPF in the course of ischemic ARF
Inulin clearance was measured to calculate GFR, and PAH clearance to estimate RPF. In the clamping group, there was a strong decline in inulin (Fig. 1A) and PAH clearance (Fig. 1B) when compared to sham group, with a minimum on day 1 of the follow-up period after ischemic ARF (inulin clearance, 0.28 Ϯ 0.11 mL/min/100 g body weight in clamping group vs. 0.8 Ϯ 0.25 mL/min/ 100 g body weight in sham group; PAH clearance, 0.15 Ϯ 0.13 mL/min/100 g body weight in clamping group vs. 1.88 Ϯ 0.55 mL/min/100 g body weight in sham group). During the following days, GFR and RPF improved in a nearly linear manner to reach 73.5% of inulin clearance of sham group on day 14, and 58.0% of PAH clearance of sham group on day 11 ( Fig. 1) . In l-Arg-substituted animals, inulin and PAH clearances were also lowest on day 1 after induction of ischemic ARF, but significantly improved during the 14 days of follow-up when compared to clamping group (Fig. 1) . In contrast, application of the stereoisomeric d-Arg had no influence on inulin and PAH clearances compared to clamping group (data not shown).
Superoxide radical detection
Impaired renal function during the course of ischemic ARF could partly result from increased oxidative stress. We therefore attempted to directly measure oxygen radi- rescence at all time points. EtBr fluorescence was lowest in sham-treated animals (Fig. 2 A) . A semiquantitative evaluation of superoxide formation is presented in Fig-RESULTS ure 2 B. Combining histologic and fluorescence pictures Pharmacokinetics and effects on blood pressure of animals evaluated on day 1 revealed that fluorescence intensity was highest in tubular structures, while it was To rule out NOS-independent effects resulting from protein supplementation, the stereoisomeric d-Arg was less pronounced in glomerula or interstitial matrix (Fig.  2 C) . EtBr fluorescence was distinctly stronger in cortical used in the same manner as described for l-Arg.
In order to compensate for the longer plasma halfkidney segments compared to medullary segments in all groups analyzed (data not shown). life of d-Arg in comparison to l-Arg, as detected in preliminary experiments, the intraperitoneally used d-Arg Expression of NOS dose was adjusted to 125 mg/kg body weight (vs. 500 mg/kg body weight l-Arg), resulting in comparable seExpression of NOS, particularly the balance of iNOS and eNOS, are considered to play a major role in the rum concentrations (Table 1 ). The equivalent dose for oral application of d-Arg was adjusted to 0.125% (vs.
course of ischemic ARF. Evaluating exemplary days during follow-up after initiation of ischemic ARF, we de-1% l-Arg).
Values of MAP and heart rate were recorded continutected a fourfold and, compared to sham, significant upregulation of iNOS, peaking on day 1 (Fig. 3) . Expression ously for 6 hours. MAP and heart rate were not influenced by l-Arg or d-Arg supplementation, and mortality of iNOS in l-Arg-treated animals was also stronger com- of soluble guanylyl cyclase ␤ were detected for soluble pared to sham, albeit the increase in expression was only guanylyl cyclase ␣ (data not shown). 1.6-fold.
eNOS was slightly up-regulated on the first days after Expression of cGK-I intervention (Fig. 4) 
with a significantly decreased eNOS
In order to analyze whether soluble guanylyl cyclase expression in l-Arg group when compared to clamping up-regulation affected the signaling cascade downstream group on the second day of follow-up. In the second of the nitric oxide/cGMP pathway, we measured the week of postinterventional follow-up, there was a trend expression of cGMP-dependent protein kinases, cGK-I for down-regulation of eNOS, albeit this did not reach and cGK-II. Cortical and medullary expression of cGK-I, statistical significance (0.05 Ͻ P Ͻ 0.1) (Fig. 4) . A repreas well as expression of cGK-II in the clamping group, sentative Western blot analysis of eNOS expression in did not differ from sham group and was not influenced both treatment groups clamping and l-Arg is depicted by l-Arg treatment during the follow-up after ischemic in Figure 4 .
ARF (representative blots of cortical cGK-I expression are depicted in Fig. 6 ).
Expression of soluble guanylyl cyclase after ischemic ARF
Increased O Ϫ 2 formation, together with an imbalance DISCUSSION in the expression of iNOS and eNOS, might lead to a
We established an animal model of ischemic ARF and functional nitric oxide deficiency in ischemic ARF [29] .
closely monitored several parameters of renal function In order to evaluate this hypothesis, we measured expresover a prolonged follow-up period of 14 days. Furthersion of the nitric oxide receptor soluble guanylyl cyclase. more, we analyzed potential biochemical mechanisms Ischemic ARF resulted in an upregulation of soluble involved in renal ischemia/reperfusion (I/R) injury. Parguanylyl cyclase ␤ expression, with a maximal expression ticular emphasis was placed on the nitric oxide pathway on day 11 in the clamping group (Fig. 5) . l-Arg treatment and on oxidative stress. Finally, the impact of l-Arg significantly prevented upregulation of soluble guanylyl supplementation on renal function and biochemical markcyclase. Representative Western blots of soluble guanyers of nitric oxide signaling was investigated. lyl cyclase expression during the follow-up period are Our model of ischemic ARF resulted in a significant and, over 14 days, partly reversible reduction of GFR shown in Figure 5 . Similar changes as in the expression Our general interpretation is that renal ischemia leads lation of soluble guanylyl cyclase and of iNOS, and to decreased nitric oxide bioavailability, despite initial prevented partly up-regulation of NT.
up-regulation of iNOS. This assumption is based primarThese results further corroborate and extend that the ily on the up-regulation of the nitric oxide receptor solunitric oxide pathway is fundamentally altered in ARF ble guanylyl cyclase during the recovery phase of isch- [4, 5] . Previous studies examined short-term I/R injury; emic ARF, together with the moderate down-regulation our present experimental design allowed observations of eNOS and the beneficial effect of l-Arg. In this conover a prolonged period of time. Here we show that text, one has to distinguish between nitric oxide derived alterations of the nitric oxide pathway take place not from constitutive eNOS and from the iNOS. While only during the acute phase of ARF, but rather last until eNOS-derived nitric oxide is believed to be responsible the end of the recovery phase. In particular, our findings for maintaining physiologic renal hemodynamics and indicate that it is important to differentiate between inifunctions, iNOS-derived nitric oxide predominantly elictial changes and resulting consequences for the recovery its pathologic effects [35] . Thus, even under the condition phase. Up-regulation of iNOS is an early event that may of up-regulated iNOS, there may be a relative nitric lead temporarily to increased levels of nitric oxide. In oxide deficiency at sites of physiologic nitric oxide action. contrast to eNOS-derived nitric oxide, nitric oxide proIt is commonly accepted that in states of nitric oxide deficiency soluble guanylyl cyclase sensitivity is up-reguduced by the iNOS seems to be causally linked to the lated [36, 37] . Decreased nitric oxide activity in the proximal tubular cells in terms of lactate dehydrogenase (LDH) release after hypoxia/reoxygenation [49] , and incourse of ARF has been described in various short-term experimental models [22, 38, 39] . Our observation of a creased lipid peroxidation after l-Arg infusion has also been observed [50] . In the study by Schramm et al [22] , potent up-regulation of soluble guanylyl cyclase in the follow-up period emphasizes the importance of a relative using a model of toxic ARF, tissue l-Arg levels were reduced, but still clearly above the K m value for saturanitric oxide deficiency in ischemic ARF.
Nitric oxide deficiency may result from decreased fortion of NOS [22] . However, supplementation of l-Arg had beneficial effects for kidney function, describing the mation or increased degradation. The results of our present study provide evidence for both mechanisms. It has so-called "l-Arg paradox" [23] . Various mechanisms have been discussed for this perplexing effect of l-Arg been suggested that the balance between expression and activity of the inducible and constitutive isoforms of NOS [23] . Those include compartmentalization of the l-Arg pool in the cytoplasm, leading to lower concentrations is disturbed in ARF, and that these changes contribute to ARF pathophysiology [35] . In particular, up-regulain vicinity to the eNOS than expected from levels in tion of iNOS may lead to down-regulation of eNOS [40] .
the serum or tissue homogenates. A recent study by Our data showing initial up-regulation of iNOS shortly
McDonald et al [51] indicates that eNOS is colocalized in after induction of ischemic ARF confirm previous recytoplasmic membrane caveolea with the cationic amino ports [34, 41] . The moderate down-regulation of eNOS acid transporter 1 (CAT-1). As a result, extracellular may be a consequence of iNOS up-regulation and is well l-Arg might be utilized rapidly by eNOS in such a microin line with the hypothesis of an imbalance between environment, and tissue or serum levels of l-Arg do not eNOS and iNOS in ischemic ARF.
necessarily reflect the substrate pool available for the However, increased inactivation of nitric oxide may enzyme. This may be of particular relevance in the setting also be relevant for our observations. As outlined above, of ischemic ARF, since it has been shown recently that nitric oxide rapidly reacts with O [45] or, in case deficiency [54] . The fact that l-Arg lowered cortical of l-Arg deficiency, uncoupled NOS itself [46] . Another O Ϫ 2 formation in our model is well in line with this interfactor that might contribute to enhanced oxidative stress pretation. in inschemic ARF has been reported in experimentally induced renal warm ischemia. In this rat model, enzy-CONCLUSION matic activity of various antioxidants [superoxide dismutase (SOD), glutathion peroxidase, catalase] was signifiIschemic ARF is accompanied by marked alterations cantly reduced [47] .
in the expression of key enzymes of the nitric oxide The beneficial effect of the nitric oxide precursor l-Arg pathway, indicative for deficiency of constitutive NOS on the course of ischemic ARF provides the third line activity. l-Arg supplementation reduces O Ϫ 2 generation of evidence for a functional nitric oxide deficiency. l-Arg and significantly improves the expression of nitric oxide not only improved GFR and RPF, but prevented almost signaling proteins as well as the recovery phase of ischcompletely the up-regulation of soluble guanyclyl cyclase emic ARF. and of iNOS, partially the up-regulation of NT, and reduced O Ϫ 2 formation. This is suggestive for a relative ACKNOWLEDGMENTS l-Arg deficiency during I/R injury, as it has been deThe skillful technical assistance of Mrs. Elke Baumeister, Mrs. Sylvia scribed before [22, 48] . In addition to beneficial effects Renker, and Mr. Manfred Bernhard is gratefully acknowledged. We also thank Dr. Dierk Brockmeier for determination of arginine levels, of l-Arg on renal hemodynamics, Jerkic et al [48] ob- 
